Finance

Lists
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
၆၄.၁၉ US$
-၀.၉၃%
(-၀.၆၀) 1D
၆၄.၁၉ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARWR...
Open
၆၅.၅၇ US$
High
၆၆.၁၆ US$
Low
၆၃.၉၉ US$
Mkt. cap
၉၀၆.၇၁ ဋေ
Avg. vol.
၁.၉၄ သန်း
Volume
၁.၄၉ သန်း
52-wk high
၉၅.၄၉ US$
52-wk low
၃၄.၆၁ US$
EPS
-၂.၂၄ US$
Beta
၁.၃၀
Shares outstanding
၁၄.၁၃ ကုဋေ
No. of employees
၇၁၁
Open
၆၅.၅၇ US$
High
၆၆.၁၆ US$
Low
၆၃.၉၉ US$
Mkt. cap
၉၀၆.၇၁ ဋေ
Avg. vol.
၁.၉၄ သန်း
Volume
၁.၄၉ သန်း
52-wk high
၉၅.၄၉ US$
52-wk low
၃၄.၆၁ US$
EPS
-၂.၂၄ US$
Beta
၁.၃၀
Shares outstanding
၁၄.၁၃ ကုဋေ
No. of employees
၇၁၁
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၅ နာရီ
Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees၇၁၁
Founded၂၀၀၄ ဇန် ၁
HeadquartersPasadena, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to ARWR in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ARWR in the last 3 months.
Highest
Current ၆၄.၁၉ US$
၁၂၆.၀၀ US$ (+၉၆.၂၉%)
Average
၁၀၉.၁၁ US$ (+၆၉.၉၈%)
Lowest
၇၄.၀၀ US$ (+၁၅.၂၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrea Newkirk
Goldman Sachs
Hold
Initiated
၇၄.၀၀ US$
+၁၅.၃%
09/24/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
၁၂၀.၀၀ US$
+၈၆.၉%
09/21/2026
Eric Joseph
Citi
Buy
Reiterated
-
-
09/16/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
-
-
09/15/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
၁၂၀.၀၀ US$
+၈၆.၉%
08/31/2026
Luca Issi
RBC Capital
Buy
Maintained
၁၀၀.၀၀ US$
+၅၅.၈%
08/30/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
၁၀၄.၀၀ US$
+၆၂%
08/31/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
08/30/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
၁၂၃.၀၀ US$
+၉၁.၆%
08/05/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
၁၂၆.၀၀ US$
+၉၆.၃%
08/05/2026
Jason Gerberry
Bank of America Securities
Buy
Reiterated
၁၀၀.၀၀ US$
+၅၅.၈%
08/04/2026
Keay Nakae
Chardan Capital
Buy
Maintained
၁၁၅.၀၀ US$
+၇၉.၂%
08/04/2026
William Pickering
Bernstein
Hold
Reiterated
၄၆.၀၀ US$
-၂၈.၃%
05/13/2026
Mani Foroohar
Leerink Partners
Hold
Maintained
-
-
03/26/2026
Last report
၂၀၂၆ ဩ ၄
Fiscal period
Q3 2026
EPS / Est. (USD)
-၁.၃၆ US$ / -၁.၂၃ US$
-၁၀.၃၅%miss
Revenue / Est. (USD)
၇.၅၃ ကုဋေ / ၄.၄၀ ကုဋေ
+၇၀.၉၉%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၅.၆၅ ကုဋေ
၂၆.၄၀ ကုဋေ
၇.၃၇ ကုဋေ
၇.၅၃ ကုဋေ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁၈.၁၁ ကုဋေ
၁၇.၃၅ ကုဋေ
၁၆.၅၇ ကုဋေ
၁၉.၁၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၁၃ ကုဋေ
၄.၉၇ ကုဋေ
၄.၉၃ ကုဋေ
၅.၄၁ ကုဋေ
Operating expense
၂၁.၂၄ ကုဋေ
၂၂.၃၂ ကုဋေ
၂၁.၅၀ ကုဋေ
၂၄.၅၃ ကုဋေ
Total operating expenses
၂၁.၂၄ ကုဋေ
၂၂.၃၂ ကုဋေ
၂၁.၅၀ ကုဋေ
၂၄.၅၃ ကုဋေ
Operating income
၄.၄၁ ကုဋေ
၄.၀၈ ကုဋေ
-၁၄.၁၃ ကုဋေ
-၁၇.၀၁ ကုဋေ
Other non operating income
၄.၆၆ သန်း
၂.၇၇ သိန်း
-၁.၆၁ သန်း
၁.၂၈ သန်း
EBT including unusual items
၃.၆၁ ကုဋေ
၂.၈၃ ကုဋေ
-၁၃.၇၆ ကုဋေ
-၁၇.၈၉ ကုဋေ
EBT excluding unusual items
၃.၆၁ ကုဋေ
၂.၈၃ ကုဋေ
-၁၅.၆၆ ကုဋေ
-၁၇.၈၉ ကုဋေ
Income tax expense
၂.၀၀ ကုဋေ
၂.၉၀ သောင်း
၇.၀၀ ထောင်
၁.၁၀ သောင်း
Effective tax rate
၅၅.၃၇%
၀.၁၀%
-၀.၀၁%
-၀.၀၁%
Other operating expenses
-
-
-
-
Net income
-၂.၃၈ ကုဋေ
၃.၀၈ ကုဋေ
-၁၃.၂၇ ကုဋေ
-၁၉.၄၃ ကုဋေ
Net profit margin
-၉.၂၆%
၁၁.၆၇%
-၁၈၀.၀၁%
-၂၅၈.၁၇%
Earnings per share
-၀.၁၈
၀.၂၂
-၀.၉၃
-၁.၃၆
Interest and investment income
၉.၀၅ သန်း
၉.၆၉ သန်း
၁.၆၉ ကုဋေ
၁.၆၉ ကုဋေ
Interest expense
-၂.၁၇ ကုဋေ
-၂.၂၅ ကုဋေ
-၂.၃၈ ကုဋေ
-၂.၄၆ ကုဋေ
Net interest expenses
-၁.၂၆ ကုဋေ
-၁.၂၈ ကုဋေ
-၆.၉၈ သန်း
-၇.၆၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၅.၀၅ ကုဋေ
၄.၇၂ ကုဋေ
-၁၃.၄၉ ကုဋေ
-၁၆.၃၄ ကုဋေ
Gain or loss from assets sale
-
-
-၁.၉၀ ကုဋေ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ